near-significantP=0.061
The only noteworthy data for weight was found in patients who received goserelin, who experienced a near-significant amount of weight gain (3.0% vs. 0.2%; P=0.061).
The only noteworthy data for weight was found in patients who received goserelin, who experienced a near-significant amount of weight gain (3.0% vs. 0.2%; P=0.061).